Ninety percent of patients who die from cancer die from metastasis, the process of the malignant cell spread throughout the body where they interfere with organ function leading to organ failure and death.  

 

We developed a Reconstructed Metastasis (rMet™) platform to separate tumor cells and isolate those with the ability to spread and cause metastasis.  Using this technology we are developing new therapies to prevent and treat metastatic cancer.